Back to search

Article

Pyrazinamide triggers degradation of its target aspartate decarboxylase

2019-06-18

Abstract excerpt

The introduction of pyrazinamide (PZA) in the tuberculosis drug regimen shortened treatment from 12 to 6 months 1 . PZA is a prodrug that is activated by a Mycobacterium tuberculosis (Mtb) amidase to release its bioactive component pyrazinoic acid (POA) 2 . Aspartate decarboxylase PanD, a proenzyme activated by autocatalytic cleavage (Supplementary Fig. 1A, 3 ) and required for Coenzyme A (CoA) biosynthesis, e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eebe0430-6c1a-5d4a-973a-6b8ce06bcf6a
DOI
10.1101/674416
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pyrazinamide triggers degradation of its target aspartate decarboxylaseDOI 10.1101/674416
Select a neighboring publication to make it the new centre.